Dysregulation of DNA methyltransferases is linked to a variety of human diseases, with DNMT3A mutations particularly implicated in hematological cancers and DNMT3B mutations associated with ICF syndrome34. Here, DNMT3A is linked to hematopoietic and lymphoid cell neoplasm.